Domov › Rakovina pľúc › Connecticut

Klinické štúdie Rakovina pľúc v štáte Connecticut

30 štúdií pre Rakovina pľúc hľadá účastníkov v zariadeniach v štáte Connecticut.

Mestá v štáte Connecticut

Oficiálny text štúdie (anglicky)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Smilow Cancer Hospital-Derby Care Center, Derby
Smilow Cancer Hospital Care Center-Fairfield, Fairfield
Smilow Cancer Hospital Care Center at Greenwich, Greenwich
a 9 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT04267848

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Yale Cancer Center, New Haven

Prebieha náborFáza 1/2

Vek 12 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT04585750

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Yale Cancer Center, New Haven

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06172478

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Stamford Hospital/Bennett Cancer Center, Stamford
Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven

Prebieha náborFáza 3

Vek 70 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06096844

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Smilow Cancer Hospital-Derby Care Center, Derby
Smilow Cancer Hospital Care Center-Fairfield, Fairfield
Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury
a 14 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT04181060

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Hartford HealthCare - Avon, Avon
Hartford Hospital, Hartford
Hartford HealthCare - Manchester, Manchester
a 2 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06498635

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

Yale University, Smillow Cancer Center, New Haven

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT06881784

Phase 1 Study of PF-08046033 in Advanced Solid Tumors

Smilow Cancer Hospital - Yale New Haven Health, New Haven
Yale - New Haven Hospital - Yale Cancer Center, New Haven
Smilow Cancer Hospital Phase 1 Unit, New Haven
a 2 ďalších

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07519655

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Stamford Hospital ( Site 0083), Stamford

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06312137

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Research Site, New Haven

Prebieha náborFáza 2

Vek 18 až 95 · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT05061550

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

Yale Cancer Center, New Haven

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 9. 2026 · NCT07349537

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

Yale University, New Haven
Yale-New Haven Hospital North Haven Medical Center, North Haven
Smilow Cancer Hospital Care Center-Trumbull, Trumbull

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 9. 2026 · NCT06287775

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Yale University School of Medicine - Yale Cancer Center, New Haven

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 16. 9. 2026 · NCT05786924

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Hartford Hospital, Hartford

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 8. 9. 2026 · NCT06793215

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Yale University School of Medicine, New Haven

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 8. 9. 2026 · NCT06119581

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Avenzo Therapeutics Recruiting Site, New Haven

Prebieha náborFáza 1/2

Vek 18 až 75 · Všetky pohlavia · Aktualizované 4. 9. 2026 · NCT07038343

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

Yale Cancer Center, New Haven
Norwalk Hospital, Norwalk

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT06343402

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Xencor Investigative Site, New Haven

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 8. 2026 · NCT05433142

A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

Yale University Cancer Center, New Haven

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 7. 2026 · NCT05652686

Integrated Cancer Repository for Cancer Research

Hartford HealthCare Cancer Institute at Manchester Medical Hospital, Manchester

Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov

Vek 19 až 110 · Všetky pohlavia · Aktualizované 29. 6. 2026 · NCT02012699

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Smilow Cancer Hospital-Derby Care Center, Derby
Smilow Cancer Hospital Care Center-Fairfield, Fairfield
Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury
a 11 ďalších

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 6. 2026 · NCT05642572

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Smilow Cancer Hospital (Yale University), New Haven

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 6. 2026 · NCT06040541

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Smilow Cancer Hospital-Derby Care Center, Derby
Smilow Cancer Hospital Care Center-Fairfield, Fairfield
Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury
a 10 ďalších

Prebieha náborFáza 2

18 Minutes · Všetky pohlavia · Aktualizované 5. 5. 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Smilow Cancer Hospital-Derby Care Center, Derby
Smilow Cancer Hospital Care Center-Fairfield, Fairfield
Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury
a 10 ďalších

Prebieha náborFáza 2/3

Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 5. 2026 · NCT06616584

Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers

Yale New Haven Medical Center, New Haven

Prebieha náborVítaní zdravých dobrovoľníkov

Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 3. 2026 · NCT06196008

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Hartford Hospital (site 210), Hartford

Prebieha náborFáza 1/2

Vek 18 až 80 · Všetky pohlavia · Aktualizované 11. 12. 2025 · NCT03556228

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Hartford
Massive Bio SYNERGY-AI site, Norwalk

Prebieha náborObservačná štúdia

Všetky vekové kategórie · Všetky pohlavia · Aktualizované 28. 10. 2025 · NCT03452774

The Natural History and Biological Study of Pulmonary Recurrent Respiratory Papillomatosis (pRRP)

Yale School of Medicine, New Haven

Prebieha náborObservačná štúdia

Vek 18 až 99 · Všetky pohlavia · Aktualizované 12. 8. 2025 · NCT06412172

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Stamford Hospital, Stamford

Prebieha náborObservačná štúdia

Vek 50 a viac · Všetky pohlavia · Aktualizované 5. 8. 2025 · NCT06122077

Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier

Trinity Health Of New England, Hartford
The Stamford Health/The Stamford Hospital, Stamford

Prebieha náborObservačná štúdia

Vek 29 až 85 · Všetky pohlavia · Aktualizované 13. 11. 2024 · NCT06426628

Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.